Clinical Trials Directory

Trials / Completed

CompletedNCT03214055

Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy

Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy: a Prospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
Male
Age
20 Years – 79 Years
Healthy volunteers
Not accepted

Summary

We aim to evaluate the change in optic nerve sheath diameters as a surrogate of intracranial pressure before and after mannitol administration in patients who undergo robot assisted laparoscopic radical prostatectomy with pneumoperitoneum and Trendelenburg position.

Detailed description

Mannitol has been frequently used for renal protection during surgery. Optic nerve sheath diameter is used to evaluate intracranial pressure noninvasively. Robot-assisted laparoscopic radical prostatectomy can induce an increase in optic nerve sheath diameter due to Trendelenburg position and carbon dioxide insufflation. We therefore aim to evaluate the change in optic nerve sheath diameters before and after mannitol administration in patients who undergo robot assisted laparoscopic radical prostatectomy.

Conditions

Interventions

TypeNameDescription
DRUGMannitolThe mannitol has been administered routinely to prevent renal dysfunction in patients undergoing robot-assisted laparoscopic radical prostatectomy. Participants will receive the mannitol as part of routine medical care, and we will evaluate the change in optic nerve sheath diameters before and after mannitol administration.

Timeline

Start date
2017-07-12
Primary completion
2017-08-14
Completion
2017-08-20
First posted
2017-07-11
Last updated
2017-08-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03214055. Inclusion in this directory is not an endorsement.